Join Azra Borogovac, MD, MS, from City of Hope, Nicole McEntee, MSN, RN, OCN, BMTCN, of RWJ Barnabas Health, and Nancy C. Long, MSN, APRN, AG-ACNP-BC, of Vanderbilt University Medical Center, as they examine the critical role of advanced practice providers (APPs) in advancing the care of patients with non-Hodgkin lymphoma (NHL) with chimeric antigen receptor (CAR) T-cell therapy. The program will explore the latest evidence for treatment strategies, monitoring and management of adverse events (AEs), and patient and caregiver counseling. Faculty will discuss the implications of new studies for clinical practice, with a focus on APP-specific strategies for effectively integrating evidence into patient care. Participants will gain the latest clinical insights and practical strategies to improve outcomes for patients with NHL receiving CAR T-cell therapy.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
82% of listed courses are free
78 of 95 courses listed here are free.
Collected from the provider’s public pages · source
Specialties served/covered
- Cardiothoracic Surgery
- Cardiovascular Disease
- Child & Adolescent Psychiatry
- Communication & Shared Decision-Making
- Comprehensive & Board Review
- Dermatology
- Endocrinology, Diabetes & Metabolism
- Evidence-Based Medicine & Research
- Family Medicine
- Gastroenterology
- General & Adult Psychiatry
- General Internal Medicine
- General Otolaryngology
- General Pediatrics
- Head & Neck Surgery
- Health Equity & Inclusion
- Hematology
- Hospital Medicine
- Infectious Disease
- Interventional Cardiology
- Medical Oncology
- Nephrology
- Neurodevelopmental Disabilities
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Obstetrics & Gynecology
- Ophthalmology
- Orthopaedic Surgery
- Pain Medicine
- Pediatric Infectious Diseases
- Pediatric Neurology
- Physical Medicine & Rehabilitation
- Practice Management & Ethics
- Preventive Medicine
- Pulmonary Disease
- Rheumatology
- Sleep Medicine
- Spine Surgery
- Urology
- Cardio-Vascular
- Cross-Specialty
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pain & Palliative
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Rehabilitation
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 1 credit
- Commercial Support
-
ReleasedOct 17, 2025
-
Last day to claim creditOct 18, 2026 6 days left
-
Plexus Communications +1 Implementing CAR T-Cell Therapies for B-Cell Lymphoma in the Community Setting: Steps to Success Empowering Peer-to-Peer Education
-
PRIME Education, Inc. (PRIME®) Expert Strategies for Identifying Eligible Patients With DLBCL and FL for CAR T-Cell Therapy
-
Annenberg Center for Health Sciences at Eisenhower Interprofessional Care of Patients Treated with CAR T-Cell Therapy
-
Haymarket Medical Education ASH 2025 : The Growing Role of CAR T-Cell Therapy in Multiple Myeloma: New Data on Earlier Lines of Therapy, Expanding Access to Treatment
-
Haymarket Medical Education The Promise of Emerging CAR Ts in RRMM: Strategies to Improve Adoption in the Community
-
Haymarket Medical Education EXPERT PERSPECTIVE #1 The Evolving Role of CAR-T Therapy in RRMM: Access and Evidence
